ALBRIOZA

Approval Id: a3aa7a3f31b042ff
Drug Approval Canada Name: ALBRIOZA
Product Name: ALBRIOZA
Status: Cancelled Post Market
Status Date: 2024-09-23
Original Market Date: 2022-07-29
Din: 02527707
Drug Class: Human
Dosage Form: Powder For Suspension
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:92.00
Atc Original: N07XX19 SODIUM PHENYLBUTYRATE AND URSODOXICOLTAURINE
Atc Name: n 07 xx 19
Aig Number: 0263762001
Company Name: Amylyx Pharmaceuticals
Company Address: 43 Thorndike Street, Cambridge, Massachusetts, United States, 02141
Company Detail Path: /organization/amylyx-pharmaceuticals

URSODOXICOLTAURINE

1 G / SACHET

SODIUM PHENYLBUTYRATE

3 G / SACHET

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a3aa7a3f31b042ff

Type

Standard